Global Drug Rehabilitation Drugs Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Drug Rehabilitation Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Drug Rehabilitation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Opioids
  • 1.2.3 Non-opioid Drugs
• 1.3 Market by Application
  • 1.3.1 Global Drug Rehabilitation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Hospital
  • 1.3.3 Clinic
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Drug Rehabilitation Drugs Sales Estimates and Forecasts 2018-2029
• 2.2 Global Drug Rehabilitation Drugs Revenue by Region
  • 2.2.1 Global Drug Rehabilitation Drugs Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Drug Rehabilitation Drugs Revenue by Region (2018-2023)
  • 2.2.3 Global Drug Rehabilitation Drugs Revenue by Region (2024-2029)
  • 2.2.4 Global Drug Rehabilitation Drugs Revenue Market Share by Region (2018-2029)
• 2.3 Global Drug Rehabilitation Drugs Sales Estimates and Forecasts 2018-2029
• 2.4 Global Drug Rehabilitation Drugs Sales by Region
  • 2.4.1 Global Drug Rehabilitation Drugs Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Drug Rehabilitation Drugs Sales by Region (2018-2023)
  • 2.4.3 Global Drug Rehabilitation Drugs Sales by Region (2024-2029)
  • 2.4.4 Global Drug Rehabilitation Drugs Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Drug Rehabilitation Drugs Sales by Manufacturers
  • 3.1.1 Global Drug Rehabilitation Drugs Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Drug Rehabilitation Drugs Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Rehabilitation Drugs in 2022
• 3.2 Global Drug Rehabilitation Drugs Revenue by Manufacturers
  • 3.2.1 Global Drug Rehabilitation Drugs Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Drug Rehabilitation Drugs Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Drug Rehabilitation Drugs Revenue in 2022
• 3.3 Global Key Players of Drug Rehabilitation Drugs, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Drug Rehabilitation Drugs Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Drug Rehabilitation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Drug Rehabilitation Drugs, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Drug Rehabilitation Drugs, Product Offered and Application
• 3.8 Global Key Manufacturers of Drug Rehabilitation Drugs, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Drug Rehabilitation Drugs Sales by Type
  • 4.1.1 Global Drug Rehabilitation Drugs Historical Sales by Type (2018-2023)
  • 4.1.2 Global Drug Rehabilitation Drugs Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• 4.2 Global Drug Rehabilitation Drugs Revenue by Type
  • 4.2.1 Global Drug Rehabilitation Drugs Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Drug Rehabilitation Drugs Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• 4.3 Global Drug Rehabilitation Drugs Price by Type
  • 4.3.1 Global Drug Rehabilitation Drugs Price by Type (2018-2023)
  • 4.3.2 Global Drug Rehabilitation Drugs Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Drug Rehabilitation Drugs Sales by Application
  • 5.1.1 Global Drug Rehabilitation Drugs Historical Sales by Application (2018-2023)
  • 5.1.2 Global Drug Rehabilitation Drugs Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• 5.2 Global Drug Rehabilitation Drugs Revenue by Application
  • 5.2.1 Global Drug Rehabilitation Drugs Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Drug Rehabilitation Drugs Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• 5.3 Global Drug Rehabilitation Drugs Price by Application
  • 5.3.1 Global Drug Rehabilitation Drugs Price by Application (2018-2023)
  • 5.3.2 Global Drug Rehabilitation Drugs Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Drug Rehabilitation Drugs Market Size by Type
  • 6.1.1 US & Canada Drug Rehabilitation Drugs Sales by Type (2018-2029)
  • 6.1.2 US & Canada Drug Rehabilitation Drugs Revenue by Type (2018-2029)
• 6.2 US & Canada Drug Rehabilitation Drugs Market Size by Application
  • 6.2.1 US & Canada Drug Rehabilitation Drugs Sales by Application (2018-2029)
  • 6.2.2 US & Canada Drug Rehabilitation Drugs Revenue by Application (2018-2029)
• 6.3 US & Canada Drug Rehabilitation Drugs Market Size by Country
  • 6.3.1 US & Canada Drug Rehabilitation Drugs Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Drug Rehabilitation Drugs Sales by Country (2018-2029)
  • 6.3.3 US & Canada Drug Rehabilitation Drugs Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Drug Rehabilitation Drugs Market Size by Type
  • 7.1.1 Europe Drug Rehabilitation Drugs Sales by Type (2018-2029)
  • 7.1.2 Europe Drug Rehabilitation Drugs Revenue by Type (2018-2029)
• 7.2 Europe Drug Rehabilitation Drugs Market Size by Application
  • 7.2.1 Europe Drug Rehabilitation Drugs Sales by Application (2018-2029)
  • 7.2.2 Europe Drug Rehabilitation Drugs Revenue by Application (2018-2029)
• 7.3 Europe Drug Rehabilitation Drugs Market Size by Country
  • 7.3.1 Europe Drug Rehabilitation Drugs Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Drug Rehabilitation Drugs Sales by Country (2018-2029)
  • 7.3.3 Europe Drug Rehabilitation Drugs Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Drug Rehabilitation Drugs Market Size
  • 8.1.1 China Drug Rehabilitation Drugs Sales (2018-2029)
  • 8.1.2 China Drug Rehabilitation Drugs Revenue (2018-2029)
• 8.2 China Drug Rehabilitation Drugs Market Size by Application
  • 8.2.1 China Drug Rehabilitation Drugs Sales by Application (2018-2029)
  • 8.2.2 China Drug Rehabilitation Drugs Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Drug Rehabilitation Drugs Market Size by Type
  • 9.1.1 Asia Drug Rehabilitation Drugs Sales by Type (2018-2029)
  • 9.1.2 Asia Drug Rehabilitation Drugs Revenue by Type (2018-2029)
• 9.2 Asia Drug Rehabilitation Drugs Market Size by Application
  • 9.2.1 Asia Drug Rehabilitation Drugs Sales by Application (2018-2029)
  • 9.2.2 Asia Drug Rehabilitation Drugs Revenue by Application (2018-2029)
• 9.3 Asia Drug Rehabilitation Drugs Sales by Region
  • 9.3.1 Asia Drug Rehabilitation Drugs Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Drug Rehabilitation Drugs Revenue by Region (2018-2029)
  • 9.3.3 Asia Drug Rehabilitation Drugs Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Teva
  • 11.1.1 Teva Company Information
  • 11.1.2 Teva Overview
  • 11.1.3 Teva Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Teva Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Teva Recent Developments
• 11.2 Purdue Pharma
  • 11.2.1 Purdue Pharma Company Information
  • 11.2.2 Purdue Pharma Overview
  • 11.2.3 Purdue Pharma Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Purdue Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Purdue Pharma Recent Developments
• 11.3 Mallinckrodt
  • 11.3.1 Mallinckrodt Company Information
  • 11.3.2 Mallinckrodt Overview
  • 11.3.3 Mallinckrodt Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Mallinckrodt Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Mallinckrodt Recent Developments
• 11.4 Amneal Pharma
  • 11.4.1 Amneal Pharma Company Information
  • 11.4.2 Amneal Pharma Overview
  • 11.4.3 Amneal Pharma Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 Amneal Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Amneal Pharma Recent Developments
• 11.5 Collegium
  • 11.5.1 Collegium Company Information
  • 11.5.2 Collegium Overview
  • 11.5.3 Collegium Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Collegium Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Collegium Recent Developments
• 11.6 J&J
  • 11.6.1 J&J Company Information
  • 11.6.2 J&J Overview
  • 11.6.3 J&J Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 J&J Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 J&J Recent Developments
• 11.7 Endo
  • 11.7.1 Endo Company Information
  • 11.7.2 Endo Overview
  • 11.7.3 Endo Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Endo Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Endo Recent Developments
• 11.8 Pfizer
  • 11.8.1 Pfizer Company Information
  • 11.8.2 Pfizer Overview
  • 11.8.3 Pfizer Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Pfizer Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Pfizer Recent Developments
• 11.9 INSYS
  • 11.9.1 INSYS Company Information
  • 11.9.2 INSYS Overview
  • 11.9.3 INSYS Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 INSYS Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 INSYS Recent Developments
• 11.10 Mylan
  • 11.10.1 Mylan Company Information
  • 11.10.2 Mylan Overview
  • 11.10.3 Mylan Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 Mylan Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Mylan Recent Developments
• 11.11 Hikma
  • 11.11.1 Hikma Company Information
  • 11.11.2 Hikma Overview
  • 11.11.3 Hikma Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.11.4 Hikma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Hikma Recent Developments
• 11.12 Egalet
  • 11.12.1 Egalet Company Information
  • 11.12.2 Egalet Overview
  • 11.12.3 Egalet Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.12.4 Egalet Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Egalet Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Drug Rehabilitation Drugs Industry Chain Analysis
• 12.2 Drug Rehabilitation Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Drug Rehabilitation Drugs Production Mode & Process
• 12.4 Drug Rehabilitation Drugs Sales and Marketing
  • 12.4.1 Drug Rehabilitation Drugs Sales Channels
  • 12.4.2 Drug Rehabilitation Drugs Distributors
• 12.5 Drug Rehabilitation Drugs Customers

13 Market Dynamics

• 13.1 Drug Rehabilitation Drugs Industry Trends
• 13.2 Drug Rehabilitation Drugs Market Drivers
• 13.3 Drug Rehabilitation Drugs Market Challenges
• 13.4 Drug Rehabilitation Drugs Market Restraints

14 Key Findings in The Global Drug Rehabilitation Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Drug Rehabilitation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Opioids
• Table 3. Major Manufacturers of Non-opioid Drugs
• Table 4. Global Drug Rehabilitation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 6. Global Drug Rehabilitation Drugs Revenue by Region (2018-2023) & (US$ Million)
• Table 7. Global Drug Rehabilitation Drugs Revenue by Region (2024-2029) & (US$ Million)
• Table 8. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2018-2023)
• Table 9. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2024-2029)
• Table 10. Global Drug Rehabilitation Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global Drug Rehabilitation Drugs Sales by Region (2018-2023) & (K Units)
• Table 12. Global Drug Rehabilitation Drugs Sales by Region (2024-2029) & (K Units)
• Table 13. Global Drug Rehabilitation Drugs Sales Market Share by Region (2018-2023)
• Table 14. Global Drug Rehabilitation Drugs Sales Market Share by Region (2024-2029)
• Table 15. Global Drug Rehabilitation Drugs Sales by Manufacturers (2018-2023) & (K Units)
• Table 16. Global Drug Rehabilitation Drugs Sales Share by Manufacturers (2018-2023)
• Table 17. Global Drug Rehabilitation Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 18. Global Drug Rehabilitation Drugs Revenue Share by Manufacturers (2018-2023)
• Table 19. Global Key Players of Drug Rehabilitation Drugs, Industry Ranking, 2021 VS 2022 VS 2023
• Table 20. Drug Rehabilitation Drugs Price by Manufacturers 2018-2023 (US$/Unit)
• Table 21. Global Drug Rehabilitation Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Drug Rehabilitation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Rehabilitation Drugs as of 2022)
• Table 23. Global Key Manufacturers of Drug Rehabilitation Drugs, Manufacturing Base Distribution and Headquarters
• Table 24. Global Key Manufacturers of Drug Rehabilitation Drugs, Product Offered and Application
• Table 25. Global Key Manufacturers of Drug Rehabilitation Drugs, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
• Table 28. Global Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
• Table 29. Global Drug Rehabilitation Drugs Sales Share by Type (2018-2023)
• Table 30. Global Drug Rehabilitation Drugs Sales Share by Type (2024-2029)
• Table 31. Global Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
• Table 32. Global Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
• Table 33. Global Drug Rehabilitation Drugs Revenue Share by Type (2018-2023)
• Table 34. Global Drug Rehabilitation Drugs Revenue Share by Type (2024-2029)
• Table 35. Drug Rehabilitation Drugs Price by Type (2018-2023) & (US$/Unit)
• Table 36. Global Drug Rehabilitation Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 37. Global Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
• Table 38. Global Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
• Table 39. Global Drug Rehabilitation Drugs Sales Share by Application (2018-2023)
• Table 40. Global Drug Rehabilitation Drugs Sales Share by Application (2024-2029)
• Table 41. Global Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
• Table 42. Global Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
• Table 43. Global Drug Rehabilitation Drugs Revenue Share by Application (2018-2023)
• Table 44. Global Drug Rehabilitation Drugs Revenue Share by Application (2024-2029)
• Table 45. Drug Rehabilitation Drugs Price by Application (2018-2023) & (US$/Unit)
• Table 46. Global Drug Rehabilitation Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 47. US & Canada Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
• Table 48. US & Canada Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
• Table 49. US & Canada Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
• Table 50. US & Canada Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
• Table 51. US & Canada Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
• Table 52. US & Canada Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
• Table 53. US & Canada Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
• Table 54. US & Canada Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
• Table 55. US & Canada Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 56. US & Canada Drug Rehabilitation Drugs Revenue by Country (2018-2023) & (US$ Million)
• Table 57. US & Canada Drug Rehabilitation Drugs Revenue by Country (2024-2029) & (US$ Million)
• Table 58. US & Canada Drug Rehabilitation Drugs Sales by Country (2018-2023) & (K Units)
• Table 59. US & Canada Drug Rehabilitation Drugs Sales by Country (2024-2029) & (K Units)
• Table 60. Europe Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
• Table 61. Europe Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
• Table 62. Europe Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
• Table 63. Europe Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
• Table 64. Europe Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
• Table 65. Europe Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
• Table 66. Europe Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
• Table 67. Europe Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
• Table 68. Europe Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 69. Europe Drug Rehabilitation Drugs Revenue by Country (2018-2023) & (US$ Million)
• Table 70. Europe Drug Rehabilitation Drugs Revenue by Country (2024-2029) & (US$ Million)
• Table 71. Europe Drug Rehabilitation Drugs Sales by Country (2018-2023) & (K Units)
• Table 72. Europe Drug Rehabilitation Drugs Sales by Country (2024-2029) & (K Units)
• Table 73. China Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
• Table 74. China Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
• Table 75. China Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
• Table 76. China Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
• Table 77. China Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
• Table 78. China Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
• Table 79. China Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
• Table 80. China Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
• Table 81. Asia Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
• Table 82. Asia Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
• Table 83. Asia Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
• Table 84. Asia Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
• Table 85. Asia Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
• Table 86. Asia Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
• Table 87. Asia Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
• Table 88. Asia Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
• Table 89. Asia Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 90. Asia Drug Rehabilitation Drugs Revenue by Region (2018-2023) & (US$ Million)
• Table 91. Asia Drug Rehabilitation Drugs Revenue by Region (2024-2029) & (US$ Million)
• Table 92. Asia Drug Rehabilitation Drugs Sales by Region (2018-2023) & (K Units)
• Table 93. Asia Drug Rehabilitation Drugs Sales by Region (2024-2029) & (K Units)
• Table 94. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
• Table 95. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
• Table 96. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
• Table 97. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
• Table 99. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
• Table 100. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
• Table 101. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 103. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country (2018-2023) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country (2024-2029) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country (2018-2023) & (K Units)
• Table 106. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country (2024-2029) & (K Units)
• Table 107. Teva Company Information
• Table 108. Teva Description and Major Businesses
• Table 109. Teva Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 110. Teva Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Teva Recent Developments
• Table 112. Purdue Pharma Company Information
• Table 113. Purdue Pharma Description and Major Businesses
• Table 114. Purdue Pharma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 115. Purdue Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Purdue Pharma Recent Developments
• Table 117. Mallinckrodt Company Information
• Table 118. Mallinckrodt Description and Major Businesses
• Table 119. Mallinckrodt Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 120. Mallinckrodt Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Mallinckrodt Recent Developments
• Table 122. Amneal Pharma Company Information
• Table 123. Amneal Pharma Description and Major Businesses
• Table 124. Amneal Pharma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 125. Amneal Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Amneal Pharma Recent Developments
• Table 127. Collegium Company Information
• Table 128. Collegium Description and Major Businesses
• Table 129. Collegium Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 130. Collegium Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Collegium Recent Developments
• Table 132. J&J Company Information
• Table 133. J&J Description and Major Businesses
• Table 134. J&J Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 135. J&J Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. J&J Recent Developments
• Table 137. Endo Company Information
• Table 138. Endo Description and Major Businesses
• Table 139. Endo Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 140. Endo Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Endo Recent Developments
• Table 142. Pfizer Company Information
• Table 143. Pfizer Description and Major Businesses
• Table 144. Pfizer Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 145. Pfizer Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Pfizer Recent Developments
• Table 147. INSYS Company Information
• Table 148. INSYS Description and Major Businesses
• Table 149. INSYS Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 150. INSYS Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. INSYS Recent Developments
• Table 152. Mylan Company Information
• Table 153. Mylan Description and Major Businesses
• Table 154. Mylan Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 155. Mylan Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Mylan Recent Developments
• Table 157. Hikma Company Information
• Table 158. Hikma Description and Major Businesses
• Table 159. Hikma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 160. Hikma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. Hikma Recent Developments
• Table 162. Egalet Company Information
• Table 163. Egalet Description and Major Businesses
• Table 164. Egalet Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 165. Egalet Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. Egalet Recent Developments
• Table 167. Key Raw Materials Lists
• Table 168. Raw Materials Key Suppliers Lists
• Table 169. Drug Rehabilitation Drugs Distributors List
• Table 170. Drug Rehabilitation Drugs Customers List
• Table 171. Drug Rehabilitation Drugs Market Trends
• Table 172. Drug Rehabilitation Drugs Market Drivers
• Table 173. Drug Rehabilitation Drugs Market Challenges
• Table 174. Drug Rehabilitation Drugs Market Restraints
• Table 175. Research Programs/Design for This Report
• Table 176. Key Data Information from Secondary Sources
• Table 177. Key Data Information from Primary Sources

List of Figures

• Figure 1. Drug Rehabilitation Drugs Product Picture
• Figure 2. Global Drug Rehabilitation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Drug Rehabilitation Drugs Market Share by Type in 2022 & 2029
• Figure 4. Opioids Product Picture
• Figure 5. Non-opioid Drugs Product Picture
• Figure 6. Global Drug Rehabilitation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Drug Rehabilitation Drugs Market Share by Application in 2022 & 2029
• Figure 8. Hospital
• Figure 9. Clinic
• Figure 10. Drug Rehabilitation Drugs Report Years Considered
• Figure 11. Global Drug Rehabilitation Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 12. Global Drug Rehabilitation Drugs Revenue 2018-2029 (US$ Million)
• Figure 13. Global Drug Rehabilitation Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 14. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2018-2029)
• Figure 15. Global Drug Rehabilitation Drugs Sales 2018-2029 ((K Units)
• Figure 16. Global Drug Rehabilitation Drugs Sales Market Share by Region (2018-2029)
• Figure 17. US & Canada Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
• Figure 18. US & Canada Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
• Figure 19. Europe Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
• Figure 20. Europe Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
• Figure 21. China Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
• Figure 22. China Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
• Figure 23. Asia (excluding China) Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
• Figure 24. Asia (excluding China) Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
• Figure 25. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
• Figure 26. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
• Figure 27. The Drug Rehabilitation Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 28. The Top 5 and 10 Largest Manufacturers of Drug Rehabilitation Drugs in the World: Market Share by Drug Rehabilitation Drugs Revenue in 2022
• Figure 29. Global Drug Rehabilitation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 30. Global Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• Figure 31. Global Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• Figure 32. Global Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• Figure 33. Global Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• Figure 34. US & Canada Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• Figure 35. US & Canada Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• Figure 36. US & Canada Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• Figure 37. US & Canada Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• Figure 38. US & Canada Drug Rehabilitation Drugs Revenue Share by Country (2018-2029)
• Figure 39. US & Canada Drug Rehabilitation Drugs Sales Share by Country (2018-2029)
• Figure 40. U.S. Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 41. Canada Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 42. Europe Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• Figure 43. Europe Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• Figure 44. Europe Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• Figure 45. Europe Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• Figure 46. Europe Drug Rehabilitation Drugs Revenue Share by Country (2018-2029)
• Figure 47. Europe Drug Rehabilitation Drugs Sales Share by Country (2018-2029)
• Figure 48. Germany Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 49. France Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 50. U.K. Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 51. Italy Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 52. Russia Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 53. China Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• Figure 54. China Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• Figure 55. China Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• Figure 56. China Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• Figure 57. Asia Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• Figure 58. Asia Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• Figure 59. Asia Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• Figure 60. Asia Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• Figure 61. Asia Drug Rehabilitation Drugs Revenue Share by Region (2018-2029)
• Figure 62. Asia Drug Rehabilitation Drugs Sales Share by Region (2018-2029)
• Figure 63. Japan Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 64. South Korea Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 65. China Taiwan Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 66. Southeast Asia Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 67. India Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 68. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
• Figure 69. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
• Figure 70. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
• Figure 71. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
• Figure 72. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Share by Country (2018-2029)
• Figure 73. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales Share by Country (2018-2029)
• Figure 74. Brazil Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 75. Mexico Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 76. Turkey Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 77. Israel Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 78. GCC Countries Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
• Figure 79. Drug Rehabilitation Drugs Value Chain
• Figure 80. Drug Rehabilitation Drugs Production Process
• Figure 81. Channels of Distribution
• Figure 82. Distributors Profiles
• Figure 83. Bottom-up and Top-down Approaches for This Report
• Figure 84. Data Triangulation
• Figure 85. Key Executives Interviewed